— Know what they know.
Not Investment Advice
Also trades as: JNJ.DE (XETRA) · $vol 1M · JNJ.SW (SIX)

JNJ NYSE

Johnson & Johnson
1W: +0.4% 1M: +2.5% 3M: -3.9% YTD: +12.4% 1Y: +54.2% 3Y: +58.2% 5Y: +56.0%
$234.34
+2.61 (+1.13%)
 
Weekly Expected Move ±2.9%
$214 $220 $227 $233 $240
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 69 · $564.1B mcap · 2.40B float · 0.328% daily turnover · Short 45% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
66.2 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 20.0%  ·  5Y Avg: 25.3%
Cost Advantage
52
Intangibles
74
Switching Cost
56
Network Effect
55
Scale ★
100
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. JNJ has a Narrow competitive edge (66.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 20.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$250
Low
$264
Avg Target
$283
High
Based on 6 analysts since Apr 14, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 21Hold: 16Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$263.00
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 Leerink Partners David Risinger $194 $265 +71 +18.2% $224.26
2026-04-20 Guggenheim $240 $266 +26 +14.3% $232.71
2026-04-15 Morgan Stanley $267 $283 +16 +18.1% $239.66
2026-04-15 RBC Capital $255 $265 +10 +10.4% $240.10
2026-04-15 Stifel Nicolaus Rick Wise $220 $250 +30 +4.1% $240.10
2026-04-15 Barclays Matt Miksic $217 $255 +38 +6.2% $240.10
2026-04-10 Morgan Stanley $253 $267 +14 +11.5% $239.50
2026-03-18 Morgan Stanley $262 $253 -9 +6.7% $237.19
2026-02-03 RBC Capital $240 $255 +15 +9.3% $233.35
2026-01-28 Morgan Stanley Terrance Flynn $200 $262 +62 +16.7% $224.44
2026-01-27 Loop Capital Markets Ilya Zubkov $190 $220 +30 -2.3% $225.16
2026-01-23 Guggenheim Vamil Divan $227 $240 +13 +9.8% $218.49
2026-01-22 Scotiabank Initiated $265 +20.4% $220.18
2026-01-22 Morgan Stanley Terence Flynn $197 $200 +3 -9.2% $220.37
2026-01-22 Stifel Nicolaus Rick Wise $190 $220 +30 +0.9% $218.01
2026-01-22 Goldman Sachs Asad Haider $240 $250 +10 +14.7% $218.01
2026-01-22 Wells Fargo $212 $240 +28 +10.1% $218.01
2026-01-09 Bernstein Lee Hambright $193 $208 +15 +1.1% $205.75
2025-12-30 Barclays Matt Miksic $197 $217 +20 +4.5% $207.56
2025-12-18 Goldman Sachs Asad Haider $159 $240 +81 +14.1% $210.33
2025-12-17 RBC Capital $230 $240 +10 +14.8% $209.07
2025-12-12 Morgan Stanley $190 $197 +7 -6.5% $210.60
2025-12-11 RBC Capital $209 $230 +21 +11.4% $206.54
2025-12-10 HSBC Initiated $240 +20.0% $199.96
2025-12-05 Guggenheim $166 $227 +61 +12.1% $202.48
2025-12-02 Barclays Initiated $197 -4.1% $205.34
2025-10-22 Johnson Rice Ilya Zubkov $150 $190 +40 -1.6% $193.18
2025-10-22 Loop Capital Markets Ilya Zubkov Initiated $190 -1.6% $193.18
2025-10-15 Argus Research David Toung $190 $210 +20 +9.8% $191.19
2025-10-15 Raymond James $162 $209 +47 +9.5% $190.85
2025-10-15 Morgan Stanley Terence Flynn $175 $190 +15 -0.4% $190.85
2025-10-15 Stifel Nicolaus $170 $190 +20 -0.4% $190.85
2025-10-14 UBS $198 $214 +16 +14.3% $187.22
2025-10-10 RBC Capital Shagun Singh $181 $209 +28 +9.3% $191.29
2025-10-06 Bernstein Initiated $193 +2.3% $188.64
2025-10-03 UBS $180 $198 +18 +6.5% $185.98
2025-10-03 Wells Fargo Larry Biegelsen $166 $212 +46 +14.0% $185.98
2025-04-14 Raymond James Jayson Bedford $90 $162 +72 +4.9% $154.36
2025-02-03 Guggenheim Vamil Divan Initiated $166 +9.3% $151.87
2024-10-16 Goldman Sachs Chris Shibutani $160 $159 -1 -3.2% $164.28
2024-10-16 Morgan Stanley Terence Flynn $169 $175 +6 +6.6% $164.10
2024-10-16 RBC Capital Shagun Singh $175 $181 +6 +10.3% $164.10
2024-10-16 Citigroup Joanne Wuensch $180 $185 +5 +12.7% $164.10
2024-10-15 Wells Fargo Larry Biegelsen $163 $166 +3 +1.2% $164.10
2024-10-15 Stifel Nicolaus Rick Wise $160 $170 +10 +3.6% $164.10
2024-10-15 Citigroup Joanna Wuensch $205 $180 -25 +9.9% $163.77
2024-10-14 Cantor Fitzgerald Louise Chen Initiated $215 +33.0% $161.60
2024-07-23 Johnson Rice Narumi Nakagiri $160 $150 -10 -2.7% $154.24
2024-07-17 Stifel Nicolaus Rick Wise $155 $160 +5 +1.8% $157.16
2024-05-30 Johnson Rice Chris Shibutani $170 $160 -10 +10.8% $144.44

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. JNJ receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-22 C B+
2026-04-17 B+ C
2026-02-24 A- B+
2026-02-18 B+ A-
2026-02-17 A- B+
2026-02-13 C A-
2026-01-23 A- C
2026-01-14 A A-
2026-01-03 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

62 Grade A+
Profitability
84
Balance Sheet
68
Earnings Quality
76
Growth
45
Value
43
Momentum
67
Safety
100
Cash Flow
58
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. JNJ scores highest in Safety (100/100) and lowest in Value (43/100). An overall grade of A+ places JNJ among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.11
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.60
Unlikely Manipulator
Ohlson O-Score
-8.88
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 86.9/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.09x
Accruals: -1.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. JNJ scores 5.11, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. JNJ scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. JNJ's score of -2.60 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. JNJ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. JNJ receives an estimated rating of AA (score: 86.9/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). JNJ's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
27.23x
PEG
-6.18x
P/S
5.85x
P/B
7.06x
P/FCF
33.03x
P/OCF
25.71x
EV/EBITDA
19.48x
EV/Revenue
6.39x
EV/EBIT
23.79x
EV/FCF
34.60x
Earnings Yield
3.58%
FCF Yield
3.03%
Shareholder Yield
3.14%
Graham Number
$80.35
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 27.2x earnings, JNJ commands a growth premium. Graham's intrinsic value formula yields $80.35 per share, 192% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.844
NI / EBT
×
Interest Burden
0.963
EBT / EBIT
×
EBIT Margin
0.269
EBIT / Rev
×
Asset Turnover
0.508
Rev / Assets
×
Equity Multiplier
2.479
Assets / Equity
=
ROE
27.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. JNJ's ROE of 27.5% is driven by Asset Turnover (0.508), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
20.78%
Fair P/E
50.06x
Intrinsic Value
$430.77
Price/Value
0.56x
Margin of Safety
44.18%
Premium
-44.18%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with JNJ's realized 20.8% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $430.77, JNJ appears undervalued with a 44% margin of safety. The adjusted fair P/E of 50.1x compares to the current market P/E of 27.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$234.36
Median 1Y
$254.28
5th Pctile
$180.61
95th Pctile
$358.08
Ann. Volatility
19.2%
Analyst Target
$263.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
J. Duato Chairman/CEO
$1,600,000 $15,028,948 $32,758,111
J. Wolk EVP,
CFO
$1,240,646 $6,263,486 $14,405,442
J. Taubert EVP,
WWC Innovative Medicine
$1,220,308 $6,160,665 $14,030,063
J. Reed EVP,
Innovative Medicine, R&D
$1,220,308 $6,160,665 $12,214,062
T. Schmid EVP,
WWC, MedTech
$942,308 $3,422,473 $9,336,765

CEO Pay Ratio

191:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $32,758,111
Avg Employee Cost (SGA/emp): $171,317
Employees: 138,200

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
138,200
+0.1% YoY
Revenue / Employee
$681,570
Rev: $94,193,000,000
Profit / Employee
$193,951
NI: $26,804,000,000
SGA / Employee
$171,317
Avg labor cost proxy
R&D / Employee
$106,114
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 28.9% 29.1% 30.4% 28.9% 26.8% 27.9% 23.8% 16.9% 17.3% 45.9% 48.3% 52.9% 52.2% 20.2% 20.1% 31.1% 32.3% 35.8% 35.0% 27.5% 27.50%
ROA 10.7% 10.8% 11.7% 11.1% 10.3% 10.7% 9.7% 6.9% 7.1% 18.7% 19.8% 21.7% 21.4% 8.3% 8.1% 12.5% 13.0% 14.5% 14.1% 11.1% 11.09%
ROIC 28.0% 30.2% 29.5% 29.2% 28.3% 26.1% 19.9% 20.7% 20.8% 21.2% 27.5% 26.5% 26.5% 25.4% 22.2% 21.6% 22.0% 22.9% 19.4% 20.0% 19.97%
ROCE 15.4% 15.0% 16.8% 15.6% 15.0% 16.0% 16.2% 10.9% 11.4% 11.6% 13.1% 17.1% 16.7% 15.2% 13.4% 21.1% 21.7% 24.8% 23.0% 17.8% 17.84%
Gross Margin 67.5% 68.9% 67.9% 67.6% 67.0% 69.1% 67.2% 68.0% 70.0% 69.1% 68.2% 69.6% 69.4% 69.0% 68.3% 66.4% 67.9% 69.6% 67.6% 71.5% 71.49%
Operating Margin 27.3% 29.4% 18.0% 26.1% 26.9% 28.3% 16.5% 29.9% 29.5% 29.0% 21.5% 29.3% 29.7% 23.5% 17.1% 28.8% 28.7% 29.6% 22.8% 26.6% 26.58%
Net Margin 26.9% 15.7% 19.1% 22.0% 20.0% 22.3% 14.8% -0.3% 23.9% 1.2% 18.9% 15.2% 20.9% 12.0% 15.2% 50.2% 23.3% 21.5% 20.8% 21.8% 21.76%
EBITDA Margin 36.6% 24.4% 27.2% 32.6% 31.7% 34.5% 25.9% 3.9% 39.3% 33.9% 31.9% 26.6% 34.7% 23.9% 26.3% 71.3% 36.8% 38.7% 29.3% 26.6% 26.58%
FCF Margin 25.3% 24.6% 21.1% 20.8% 20.9% 19.2% 18.9% 18.3% 16.9% 18.0% 21.4% 21.8% 23.5% 22.2% 20.3% 20.8% 18.1% 20.7% 20.9% 18.5% 18.47%
OCF Margin 29.3% 28.5% 25.0% 24.6% 24.7% 23.4% 23.3% 23.1% 22.1% 23.2% 26.8% 27.1% 28.5% 28.7% 27.3% 27.7% 25.4% 26.3% 26.0% 23.7% 23.73%
ROE 3Y Avg snapshot only 37.42%
ROE 5Y Avg snapshot only 31.12%
ROA 3Y Avg snapshot only 15.21%
ROIC 3Y Avg snapshot only 26.51%
ROIC Economic snapshot only 17.13%
Cash ROA snapshot only 11.48%
Cash ROIC snapshot only 20.91%
CROIC snapshot only 16.27%
NOPAT Margin snapshot only 22.67%
Pretax Margin snapshot only 25.88%
R&D / Revenue snapshot only 15.53%
SGA / Revenue snapshot only 25.42%
SBC / Revenue snapshot only 1.42%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 22.32 21.21 19.46 21.45 23.49 20.58 23.94 29.18 30.84 10.70 10.19 9.47 8.90 25.69 24.21 17.79 16.05 17.27 18.89 27.94 27.235
P/S Ratio 4.45 4.15 4.33 4.48 4.51 4.27 4.71 4.19 4.68 4.24 4.21 4.25 3.91 4.30 3.83 4.34 4.01 4.71 5.38 6.10 5.854
P/B Ratio 6.27 5.99 5.49 5.75 5.83 5.33 5.59 4.83 5.24 4.82 5.21 5.30 4.92 5.48 4.76 5.43 5.09 6.07 6.21 7.21 7.058
P/FCF 17.58 16.89 20.56 21.55 21.63 22.23 25.00 22.91 27.68 23.54 19.64 19.48 16.66 19.35 18.86 20.89 22.18 22.75 25.71 33.03 33.035
P/OCF 15.19 14.58 17.36 18.24 18.30 18.27 20.27 18.14 21.11 18.27 15.72 15.71 13.72 15.00 14.03 15.66 15.79 17.92 20.64 25.71 25.708
EV/EBITDA 14.59 14.27 13.46 14.94 15.66 13.71 15.78 18.09 18.82 17.13 15.64 13.15 12.51 14.94 14.23 11.53 10.54 11.27 13.09 19.48 19.477
EV/Revenue 4.56 4.26 4.36 4.51 4.54 4.30 4.90 4.39 4.88 4.43 4.28 4.33 3.98 4.37 3.97 4.48 4.15 4.84 5.67 6.39 6.390
EV/EBIT 19.96 19.67 17.79 20.03 21.14 18.13 20.93 26.98 27.91 25.46 23.04 17.84 17.00 20.85 20.22 14.60 13.33 13.86 16.03 23.79 23.789
EV/FCF 18.02 17.34 20.67 21.66 21.74 22.35 26.01 23.98 28.87 24.65 19.99 19.82 16.97 19.68 19.53 21.55 22.92 23.38 27.12 34.60 34.598
Earnings Yield 4.5% 4.7% 5.1% 4.7% 4.3% 4.9% 4.2% 3.4% 3.2% 9.3% 9.8% 10.6% 11.2% 3.9% 4.1% 5.6% 6.2% 5.8% 5.3% 3.6% 3.58%
FCF Yield 5.7% 5.9% 4.9% 4.6% 4.6% 4.5% 4.0% 4.4% 3.6% 4.2% 5.1% 5.1% 6.0% 5.2% 5.3% 4.8% 4.5% 4.4% 3.9% 3.0% 3.03%
EV/OCF snapshot only 26.925
EV/Gross Profit snapshot only 9.245
Acquirers Multiple snapshot only 23.783
Shareholder Yield snapshot only 3.14%
Graham Number snapshot only $80.35
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.21 1.21 1.35 1.35 1.35 1.35 0.99 0.99 0.99 0.99 1.16 1.16 1.16 1.16 1.11 1.11 1.11 1.11 1.03 1.03 1.028
Quick Ratio 0.99 0.99 1.12 1.12 1.12 1.12 0.81 0.81 0.81 0.81 0.91 0.91 0.91 0.91 0.86 0.86 0.86 0.86 0.77 0.77 0.765
Debt/Equity 0.56 0.56 0.46 0.46 0.46 0.46 0.52 0.52 0.52 0.52 0.43 0.43 0.43 0.43 0.51 0.51 0.51 0.51 0.59 0.59 0.588
Net Debt/Equity 0.16 0.16 0.03 0.03 0.03 0.03 0.23 0.23 0.23 0.23 0.09 0.09 0.09 0.09 0.17 0.17 0.17 0.17 0.34 0.34 0.341
Debt/Assets 0.20 0.20 0.19 0.19 0.19 0.19 0.21 0.21 0.21 0.21 0.18 0.18 0.18 0.18 0.20 0.20 0.20 0.20 0.24 0.24 0.241
Debt/EBITDA 1.27 1.29 1.11 1.18 1.22 1.17 1.40 1.85 1.78 1.75 1.26 1.04 1.06 1.14 1.48 1.06 1.03 0.93 1.17 1.52 1.516
Net Debt/EBITDA 0.36 0.37 0.07 0.07 0.08 0.07 0.61 0.81 0.78 0.77 0.27 0.23 0.23 0.25 0.49 0.35 0.34 0.31 0.68 0.88 0.880
Interest Coverage 87.06 94.27 125.46 164.15 160.27 137.54 77.36 30.13 22.91 19.09 20.51 29.06 26.40 23.92 23.10 34.09 33.48 48.23 44.79 44.40 44.400
Equity Multiplier 2.76 2.76 2.46 2.46 2.46 2.46 2.44 2.44 2.44 2.44 2.44 2.44 2.44 2.44 2.52 2.52 2.52 2.52 2.44 2.44 2.443
Cash Ratio snapshot only 0.371
Debt Service Coverage snapshot only 54.230
Cash to Debt snapshot only 0.419
FCF to Debt snapshot only 0.371
Defensive Interval snapshot only 334.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.54 0.55 0.53 0.53 0.54 0.52 0.49 0.48 0.47 0.47 0.48 0.48 0.49 0.49 0.51 0.51 0.52 0.53 0.50 0.51 0.508
Inventory Turnover 3.21 3.24 3.03 3.08 3.11 3.00 2.85 2.76 2.62 2.66 2.48 2.46 2.50 2.53 2.33 2.40 2.46 2.49 2.27 2.23 2.235
Receivables Turnover 6.36 6.52 6.50 6.58 6.62 6.39 6.22 6.04 5.87 5.97 5.89 5.92 5.99 6.07 5.98 6.01 6.10 6.20 5.88 6.02 6.019
Payables Turnover 3.26 3.29 2.90 2.96 2.99 2.88 2.81 2.73 2.59 2.63 2.72 2.70 2.74 2.78 2.75 2.84 2.92 2.95 2.71 2.67 2.669
DSO 57 56 56 56 55 57 59 60 62 61 62 62 61 60 61 61 60 59 62 61 60.6 days
DIO 114 113 121 118 117 121 128 132 139 137 147 148 146 144 157 152 148 147 161 163 163.3 days
DPO 112 111 126 123 122 127 130 134 141 139 134 135 133 131 132 129 125 124 135 137 136.8 days
Cash Conversion Cycle 59 58 51 51 50 52 57 59 60 59 75 75 74 73 86 84 83 82 88 87 87.2 days
Fixed Asset Turnover snapshot only 4.159
Operating Cycle snapshot only 224.0 days
Cash Velocity snapshot only 4.794
Capital Intensity snapshot only 2.067
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 10.8% 13.1% 13.6% 12.7% 7.2% 0.9% -2.8% -6.6% -9.9% -5.2% -6.6% -3.3% 0.5% 0.3% 4.3% 4.3% 4.7% 5.1% 6.0% 7.9% 7.87%
Net Income 17.0% 5.3% 41.9% 31.2% 3.4% 7.1% -14.1% -35.8% -28.9% 80.7% 95.9% 2.0% 1.9% -57.6% -60.0% -43.3% -40.4% 71.1% 90.6% -3.5% -3.53%
EPS 16.7% 5.0% 41.8% 31.5% 3.5% 7.7% -13.9% -34.3% -27.8% 88.6% 1.1% 2.2% 2.2% -55.5% -59.9% -43.2% -40.3% 71.0% 89.6% -4.4% -4.37%
FCF 29.4% 22.7% -2.1% -5.4% -11.6% -21.0% -13.0% -17.9% -27.1% -11.3% 6.2% 15.4% 39.6% 23.9% -1.0% -0.7% -19.2% -2.2% 9.1% -4.2% -4.18%
EBITDA 18.4% 3.5% 26.8% 14.3% -0.6% 6.0% -6.7% -24.9% -19.4% -21.7% -17.7% 31.2% 23.4% 13.4% 6.3% 23.1% 29.4% 54.0% 64.8% -8.9% -8.90%
Op. Income 15.2% 19.5% 22.0% 12.8% 2.6% -6.2% -9.7% -6.4% -7.3% -0.1% 5.6% 5.2% 7.0% 0.5% -5.8% -5.8% -6.3% 5.4% 17.0% 17.3% 17.29%
OCF Growth snapshot only -7.72%
Asset Growth snapshot only 10.61%
Equity Growth snapshot only 14.06%
Debt Growth snapshot only 30.84%
Shares Change snapshot only 0.88%
Dividend Growth snapshot only 4.86%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 3.4% 4.0% 4.8% 5.2% 5.5% 4.1% 3.6% 2.3% 2.3% 2.7% 1.0% 0.6% -1.0% -1.4% -1.8% -2.0% -1.8% -0.0% 1.1% 2.8% 2.83%
Revenue 5Y 4.7% 5.0% 5.5% 5.6% 5.7% 4.4% 3.6% 2.4% 1.3% 1.5% 0.9% 1.0% 1.3% 1.4% 1.6% 1.5% 2.4% 2.6% 2.7% 2.7% 2.73%
EPS 3Y 1.4% 1.3% 11.7% 11.0% 4.3% 10.7% 5.9% -8.7% -4.4% 28.7% 37.9% 40.9% 33.1% -3.3% -9.5% 6.6% 10.8% 12.8% 17.7% 20.8% 20.78%
EPS 5Y 4.3% 3.2% 5.5% 4.4% 2.9% 4.5% 69.3% 60.7% 58.0% 88.8% 20.8% 23.8% 20.9% 2.7% 0.5% 7.0% 10.5% 10.2% 14.8% 8.8% 8.76%
Net Income 3Y 1.3% 1.3% 10.9% 10.5% 4.0% 10.6% 5.9% -9.5% -4.9% 26.8% 33.7% 36.5% 28.9% -6.4% -12.3% 3.2% 7.3% 9.5% 14.3% 18.3% 18.25%
Net Income 5Y 3.4% 2.3% 4.8% 3.7% 2.4% 3.9% 69.0% 59.2% 56.9% 86.3% 18.1% 21.3% 18.4% 0.7% -1.4% 4.9% 8.3% 8.1% 12.7% 6.8% 6.84%
EBITDA 3Y 2.5% 2.2% 5.4% 5.0% 1.3% 6.9% 4.7% -6.9% -1.7% -4.9% -0.9% 4.0% -0.4% -2.0% -6.5% 6.7% 8.8% 11.0% 13.0% 13.7% 13.74%
EBITDA 5Y 4.4% 2.9% 4.6% 3.0% 2.3% 2.9% 3.2% -3.0% -2.9% -2.4% -2.1% 2.7% 0.7% 1.7% 0.1% 5.4% 8.7% 8.4% 11.3% 4.8% 4.78%
Gross Profit 3Y 4.1% 4.6% 5.5% 5.8% 6.2% 4.8% 4.2% 3.2% 3.7% 4.1% 2.7% 2.0% 0.0% -0.6% -1.4% -1.8% -1.7% 0.1% 1.2% 3.5% 3.50%
Gross Profit 5Y 3.9% 4.4% 4.9% 5.1% 5.2% 4.3% 3.9% 2.9% 2.2% 2.1% 1.5% 1.7% 2.0% 2.2% 2.4% 2.2% 3.1% 3.4% 3.4% 3.6% 3.61%
Op. Income 3Y 6.6% 6.2% 5.0% 4.7% 5.0% 2.9% 1.9% 1.2% 3.1% 3.8% 5.2% 3.5% 0.6% -2.0% -3.5% -2.5% -2.4% 1.9% 5.2% 5.1% 5.12%
Op. Income 5Y 4.0% 4.0% 3.0% 2.3% 2.7% 2.3% 3.2% 3.1% 2.9% 2.3% 2.0% 2.4% 2.8% 1.8% 1.0% 0.5% 1.9% 3.5% 5.1% 4.2% 4.16%
FCF 3Y 6.9% 6.7% 2.2% 2.2% 2.8% -3.4% -4.8% -6.4% -5.9% -4.9% -3.3% -3.6% -3.5% -4.6% -3.0% -2.0% -6.3% 2.4% 4.7% 3.2% 3.17%
FCF 5Y 9.4% 10.4% 4.9% 3.3% 2.5% -0.8% -0.7% -2.5% -4.7% -3.2% -0.3% 0.3% 2.0% -0.2% -1.9% -1.2% -1.2% 0.8% -0.5% -3.1% -3.12%
OCF 3Y 5.8% 5.7% 1.8% 1.7% 2.3% -2.5% -3.3% -4.1% -2.7% -2.1% -1.1% -1.5% -1.9% -1.1% 1.2% 2.1% -0.8% 3.9% 5.0% 3.8% 3.76%
OCF 5Y 7.8% 8.6% 4.5% 3.2% 2.6% -0.0% 0.1% -1.2% -2.9% -1.7% 0.5% 0.9% 2.3% 1.6% 0.7% 1.3% 2.1% 2.3% 0.8% -1.2% -1.17%
Assets 3Y 3.6% 3.6% 6.0% 6.0% 6.0% 6.0% 5.9% 5.9% 5.9% 5.9% -1.4% -1.4% -1.4% -1.4% -0.4% -0.4% -0.4% -0.4% 2.1% 2.1% 2.06%
Assets 5Y 5.6% 5.6% 5.2% 5.2% 5.2% 5.2% 3.6% 3.6% 3.6% 3.6% 1.8% 1.8% 1.8% 1.8% 2.7% 2.7% 2.7% 2.7% 2.6% 2.6% 2.64%
Equity 3Y 1.7% 1.7% 7.4% 7.4% 7.4% 7.4% 8.9% 8.9% 8.9% 8.9% 2.8% 2.8% 2.8% 2.8% -1.2% -1.2% -1.2% -1.2% 2.0% 2.0% 2.02%
Book Value 3Y 2.3% 2.4% 8.1% 7.8% 7.7% 7.5% 9.0% 9.8% 9.4% 10.6% 6.1% 6.1% 6.2% 6.2% 2.0% 2.0% 2.1% 1.9% 5.1% 4.2% 4.20%
Dividend 3Y 2.6% 2.5% 2.4% 2.0% 2.0% 2.0% 2.0% 2.8% 2.3% 2.5% 3.4% 2.8% 2.3% 2.8% 3.4% 4.0% 4.8% 4.6% 4.6% 3.8% 3.77%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.85 0.82 0.86 0.90 0.92 0.89 0.83 0.68 0.42 0.48 0.26 0.21 0.12 0.20 0.09 0.07 0.19 0.50 0.56 0.67 0.671
Earnings Stability 0.05 0.05 0.25 0.25 0.24 0.32 0.62 0.34 0.32 0.84 0.60 0.38 0.36 0.16 0.13 0.25 0.30 0.11 0.14 0.13 0.131
Margin Stability 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.98 0.982
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 0.50 0.50 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.93 0.98 0.83 0.88 0.99 0.97 0.94 0.86 0.88 0.50 0.50 0.50 0.50 0.50 0.50 0.83 0.84 0.50 0.50 0.99 0.986
Earnings Smoothness 0.84 0.95 0.65 0.73 0.97 0.93 0.85 0.56 0.66 0.42 0.35 0.00 0.02 0.19 0.14 0.45 0.49 0.48 0.38 0.96 0.964
ROE Trend 0.02 0.02 0.04 0.00 -0.02 -0.03 -0.02 -0.09 -0.09 0.18 0.25 0.34 0.34 -0.14 -0.18 -0.06 -0.04 0.02 -0.03 -0.17 -0.174
Gross Margin Trend 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 -0.00 -0.01 -0.01 -0.01 0.00 0.004
FCF Margin Trend 0.03 0.01 -0.03 -0.04 -0.03 -0.04 -0.04 -0.04 -0.06 -0.04 0.01 0.02 0.05 0.04 0.00 0.01 -0.02 0.01 0.00 -0.03 -0.028
Sustainable Growth Rate 11.4% 11.4% 14.3% 12.6% 10.2% 11.1% 8.3% 1.2% 1.5% 30.2% 32.1% 36.8% 36.3% 4.1% 3.2% 14.1% 15.1% 18.4% 18.8% 11.1% 11.13%
Internal Growth Rate 4.4% 4.4% 5.8% 5.1% 4.1% 4.5% 3.5% 0.5% 0.6% 14.1% 15.2% 17.8% 17.5% 1.7% 1.3% 6.0% 6.5% 8.0% 8.2% 4.7% 4.70%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.47 1.46 1.12 1.18 1.28 1.13 1.18 1.61 1.46 0.59 0.65 0.60 0.65 1.71 1.73 1.14 1.02 0.96 0.92 1.09 1.087
FCF/OCF 0.86 0.86 0.84 0.85 0.85 0.82 0.81 0.79 0.76 0.78 0.80 0.81 0.82 0.78 0.74 0.75 0.71 0.79 0.80 0.78 0.778
FCF/Net Income snapshot only 0.846
OCF/EBITDA snapshot only 0.723
CapEx/Revenue 4.0% 3.9% 3.9% 3.8% 3.8% 4.2% 4.4% 4.8% 5.3% 5.2% 5.3% 5.2% 5.0% 6.4% 7.0% 7.0% 7.3% 5.6% 5.1% 5.3% 5.26%
CapEx/Depreciation snapshot only 0.885
Accruals Ratio -0.05 -0.05 -0.01 -0.02 -0.03 -0.01 -0.02 -0.04 -0.03 0.08 0.07 0.09 0.08 -0.06 -0.06 -0.02 -0.00 0.01 0.01 -0.01 -0.010
Sloan Accruals snapshot only -0.052
Cash Flow Adequacy snapshot only 1.300
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 2.7% 2.9% 2.7% 2.6% 2.6% 2.9% 2.7% 3.2% 3.0% 3.2% 3.3% 3.2% 3.4% 3.1% 3.5% 3.1% 3.3% 2.8% 2.4% 2.1% 2.22%
Dividend/Share $4.03 $4.07 $4.13 $4.19 $4.25 $4.33 $4.39 $4.54 $4.55 $4.65 $4.84 $4.81 $4.79 $4.82 $4.87 $4.93 $5.00 $5.04 $5.08 $5.12 $5.20
Payout Ratio 60.6% 61.0% 52.8% 56.3% 61.7% 60.1% 65.1% 93.0% 91.6% 34.3% 33.5% 30.4% 30.5% 79.7% 84.1% 54.8% 53.3% 48.7% 46.2% 59.5% 59.52%
FCF Payout Ratio 47.7% 48.5% 55.8% 56.6% 56.8% 64.9% 68.0% 73.0% 82.2% 75.4% 64.5% 62.5% 57.1% 60.0% 65.5% 64.3% 73.7% 64.2% 62.9% 70.4% 70.36%
Total Payout Ratio 76.8% 76.5% 69.4% 74.4% 83.2% 89.9% 98.8% 1.6% 1.5% 52.0% 47.9% 38.2% 37.7% 95.8% 1.0% 68.9% 66.3% 58.3% 61.3% 87.8% 87.81%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 0
Chowder Number 0.09 0.08 0.08 0.08 0.08 0.09 0.09 0.09 0.08 0.06 0.04 0.02 0.00 0.02 0.04 0.05 0.08 0.07 0.07 0.07 0.070
Buyback Yield 0.7% 0.7% 0.9% 0.8% 0.9% 1.4% 1.4% 2.2% 1.8% 1.7% 1.4% 0.8% 0.8% 0.6% 0.7% 0.8% 0.8% 0.6% 0.8% 1.0% 1.01%
Net Buyback Yield 0.7% 0.7% 0.9% 0.8% 0.9% 1.4% 1.4% 2.2% 1.8% 1.7% 1.4% 0.8% 0.8% 0.6% 0.7% 0.8% 0.8% -0.3% 0.3% 0.8% 0.81%
Total Shareholder Return 3.4% 3.6% 3.6% 3.5% 3.5% 4.4% 4.1% 5.3% 4.8% 4.9% 4.7% 4.0% 4.2% 3.7% 4.2% 3.9% 4.1% 2.5% 2.8% 2.9% 2.94%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.88 0.91 0.92 0.93 0.90 0.88 0.85 0.91 0.91 2.40 2.33 1.92 1.95 0.83 0.84 0.82 0.83 0.80 0.82 0.84 0.844
Interest Burden (EBT/EBIT) 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.97 0.96 0.95 0.95 0.97 0.96 0.96 0.96 0.97 0.97 0.98 0.98 0.96 0.963
EBIT Margin 0.23 0.22 0.24 0.22 0.21 0.24 0.23 0.16 0.17 0.17 0.19 0.24 0.23 0.21 0.20 0.31 0.31 0.35 0.35 0.27 0.269
Asset Turnover 0.54 0.55 0.53 0.53 0.54 0.52 0.49 0.48 0.47 0.47 0.48 0.48 0.49 0.49 0.51 0.51 0.52 0.53 0.50 0.51 0.508
Equity Multiplier 2.71 2.71 2.60 2.60 2.60 2.60 2.45 2.45 2.45 2.45 2.44 2.44 2.44 2.44 2.48 2.48 2.48 2.48 2.48 2.48 2.479
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $6.65 $6.68 $7.82 $7.44 $6.88 $7.20 $6.73 $4.88 $4.97 $13.58 $14.46 $15.83 $15.70 $6.05 $5.80 $9.00 $9.37 $10.34 $10.99 $8.60 $8.60
Book Value/Share $23.69 $23.66 $27.72 $27.76 $27.75 $27.81 $28.83 $29.48 $29.25 $30.12 $28.29 $28.30 $28.40 $28.33 $29.45 $29.50 $29.55 $29.44 $33.43 $33.35 $33.20
Tangible Book/Share $-9.93 $-9.91 $-2.85 $-2.86 $-2.85 $-2.86 $0.85 $0.87 $0.86 $0.89 $-0.81 $-0.81 $-0.81 $-0.81 $-4.26 $-4.26 $-4.27 $-4.25 $-7.23 $-7.21 $-7.21
Revenue/Share $33.38 $34.19 $35.12 $35.58 $35.83 $34.66 $34.22 $34.01 $32.80 $34.31 $35.03 $35.24 $35.75 $36.12 $36.60 $36.86 $37.46 $37.94 $38.62 $39.41 $39.41
FCF/Share $8.45 $8.40 $7.40 $7.40 $7.48 $6.67 $6.45 $6.22 $5.54 $6.17 $7.51 $7.70 $8.38 $8.03 $7.44 $7.66 $6.78 $7.85 $8.08 $7.28 $7.28
OCF/Share $9.77 $9.73 $8.77 $8.74 $8.84 $8.11 $7.96 $7.86 $7.26 $7.95 $9.38 $9.54 $10.17 $10.36 $10.00 $10.22 $9.52 $9.97 $10.06 $9.35 $9.35
Cash/Share $9.43 $9.42 $11.84 $11.85 $11.85 $11.88 $8.36 $8.55 $8.49 $8.74 $9.43 $9.43 $9.47 $9.44 $10.10 $10.12 $10.14 $10.10 $8.24 $8.22 $9.02
EBITDA/Share $10.43 $10.20 $11.37 $10.73 $10.38 $10.86 $10.63 $8.25 $8.50 $8.88 $9.59 $11.60 $11.37 $10.58 $10.21 $14.32 $14.74 $16.29 $16.74 $12.93 $12.93
Debt/Share $13.20 $13.18 $12.64 $12.66 $12.65 $12.68 $14.88 $15.21 $15.10 $15.55 $12.07 $12.07 $12.11 $12.08 $15.09 $15.11 $15.14 $15.08 $19.65 $19.60 $19.60
Net Debt/Share $3.77 $3.77 $0.80 $0.80 $0.80 $0.81 $6.52 $6.66 $6.61 $6.81 $2.64 $2.64 $2.64 $2.64 $4.99 $5.00 $5.01 $4.99 $11.41 $11.38 $11.38
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.107
Altman Z-Prime snapshot only 8.934
Piotroski F-Score 7 6 8 8 8 8 5 6 6 5 6 7 6 6 7 6 6 6 5 6 6
Beneish M-Score -2.69 -2.72 -2.25 -2.23 -2.26 -2.09 -2.62 -2.71 -2.70 -2.17 -2.29 -2.26 -2.29 -2.94 -2.49 -2.25 -2.21 -2.20 -2.44 -2.60 -2.597
Ohlson O-Score snapshot only -8.881
Net-Net WC snapshot only $-25.37
EVA snapshot only $10905630713.71
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA
Credit Score 85.60 85.82 89.79 90.63 90.65 91.16 86.11 82.33 82.94 80.84 90.24 89.42 89.13 89.31 83.11 90.39 86.46 93.46 86.29 86.89 86.886
Credit Grade snapshot only 3
Credit Trend snapshot only -3.507
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 71
Sector Credit Rank snapshot only 84

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms